A carregar...

A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours

Purpose. The prognosis for patients with Ewing's tumours who have metastases at presentation or who are refractory to standard chemotherapy regimens remains poor. There is therefore a need to evaluate the role of new agents. This report describes the initial results of a prospective phase II tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Meyer, T., Mctiernan, A., Whelan, J.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2003
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395514/
https://ncbi.nlm.nih.gov/pubmed/18521364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1357714031000114192
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!